BNF:

Not listed

Status:

Do Not Prescribe (DNP), Red

Decision Date:

February 2024

Comments

RED: NICE HST30: for treating Wolman disease as per NHSE commissioning intentions (Decision date - February 2024)

DNP: NICE TA961: for treating lysosomal acid lipase deficiency that is not Wolman disease. (Terminated Appraisal). (Decision date - April 2024)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again